-
公开(公告)号：US20100217180A1
公开(公告)日：2010-08-26
申请号：US12389886
申请日：2009-02-20
Applicant: Alp Akonur , Ying-Cheng Lo
Inventor： Alp Akonur , Ying-Cheng Lo
Abstract: A method of modeling a patient's peritoneal dialysis drain phase includes (i) modeling a first segment of a drain phase curve as having a constant flowrate; (ii) modeling a second segment of a drain phase curve as having a decaying exponential flowrate; and (iii) incorporating a switching component into the first and second components so that (a) at a first time the first segment is active and while the second segment is inactive and (b) at a second time the first segment is inactive and while the second segment is active.
Abstract translation: 建模患者腹膜透析排泄阶段的方法包括（i）将排水相曲线的第一段建模为具有恒定的流速; （ii）将排水相曲线的第二段建模为具有衰减指数流速; 以及（iii）将切换组件并入到所述第一和第二组件中，使得（a）在第一时间第一段处于活动状态，而第二段处于非活动状态，并且（b）在第二时间段，第一段无效，而 第二段是活跃的。
-
公开(公告)号：US20100217179A1
公开(公告)日：2010-08-26
申请号：US12390002
申请日：2009-02-20
Applicant: Ying-Cheng Lo , Rohit Vishnoi
Inventor： Ying-Cheng Lo , Rohit Vishnoi
IPC: A61M1/28
Abstract: A peritoneal dialysis method includes (i) connecting smaller and larger supply containers to a junction, the smaller and larger supply bags both full of dialysate; (ii) allowing the junction to be connected to a patient's transfer set; allowing the patient to drain through the junction; (iii) allowing the patient to fill from the smaller supply container; and (iv) allowing the patient to refill the smaller supply container from the larger supply container.
Abstract translation: 腹膜透析方法包括（i）将较小和较大的供应容器连接到交界处，较小和较大的充满透析液的供应袋; （ii）允许接头连接到患者的转移组件; 允许患者通过交界处排出; （iii）允许患者从较小的供应容器中填充; 和（iv）允许患者将更小的供应容器从较大的供应容器中重新填充。
-
公开(公告)号：US20100198138A1
公开(公告)日：2010-08-05
申请号：US12696889
申请日：2010-01-29
Applicant: Paul R. Chapman , Brian J. Connell , Ying-Cheng Lo
Inventor： Paul R. Chapman , Brian J. Connell , Ying-Cheng Lo
CPC classification number: A61M1/285 , A61M39/12 , A61M39/28 , A61M39/286
Abstract: Transfer sets are disclosed in the present patent. The transfer set provides a connection between a source of peritoneal dialysis fluid and a patient for whom peritoneal dialysis has been prescribed. The transfer sets disclosed herein are smaller and provide a more compact and convenient device by which a dialysis patient controls the flow of dialysis fluid to and from the peritoneum of the patient. The devices are more compact and convenient because they include more convenient mechanisms for starting and stopping flow of the dialysis fluid. It is also easy to determine whether the mechanism is in a closed or open configuration by simply looking at the mechanism.
Abstract translation: 转让集合在本专利中公开。 转移组提供腹膜透析液源和已经规定了腹膜透析的患者之间的连接。 本文公开的转移组较小，并且提供更紧凑和方便的装置，通过该装置透析患者控制透过液流入和离开患者腹膜的流动。 这些装置更紧凑和便利，因为它们包括更方便的起始和停止透析液流动的机构。 通过简单地查看机制，也很容易确定机制是否处于关闭或打开配置。
-
公开(公告)号：US20100191181A1
公开(公告)日：2010-07-29
申请号：US12362259
申请日：2009-01-29
Applicant: Robert W. Childers , Peter A. Hopping , Ying-Cheng Lo
Inventor： Robert W. Childers , Peter A. Hopping , Ying-Cheng Lo
IPC: A61M1/28
CPC classification number: A61M1/284 , A61M1/28 , A61M1/281 , A61M1/282 , A61M2205/3379 , B01D61/30 , B01D61/32
Abstract: A system and method for automatically adjusting a Continuous Cycling Peritoneal Dialysis (“CCPD”) therapy to minimize the potential for excess intra-peritoneal volume. The adjustments are made at the end of the drain, just prior to the next fill. The adjustments short the next fill, if necessary, to limit the intra-peritoneal volume, add a cycle, if necessary, to use all of the available dialysis solution and will average the remaining dwell time to maximize the therapeutic benefit of the therapy in the allotted time. In another embodiment, a tidal therapy using trended patient UF data is provided.
Abstract translation: 一种用于自动调节连续循环腹膜透析（“CCPD”）治疗的系统和方法，以最大限度地减少腹膜内多余的体积。 调整是在排水结束时进行的，就在下一次填充之前。 如果需要，调整缩短下一次填充，以限制腹膜内体积，如果需要，添加一个循环，以使用所有可用的透析溶液，并将平均剩余停留时间，以最大化治疗的治疗效果 分配时间 在另一个实施例中，提供使用趋势化患者UF数据的潮汐治疗。
-
公开(公告)号：US20100004588A1
公开(公告)日：2010-01-07
申请号：US12166063
申请日：2008-07-01
Applicant: Rosa H. Yeh , Wei Xie , Hsinjin E. Yang , Michael T. K. Ling , Ying-Cheng Lo
Inventor： Rosa H. Yeh , Wei Xie , Hsinjin E. Yang , Michael T. K. Ling , Ying-Cheng Lo
CPC classification number: A61M1/3486 , A61M1/14 , A61M1/16 , A61M1/1619 , A61M1/1696 , A61M1/28 , A61M1/284 , A61M1/34 , A61M1/3406 , A61M1/3413 , A61M1/3472 , A61M2202/0498 , A61M2205/0211 , A61M2205/12 , A61M2205/125 , A61M2205/126 , A61M2205/15 , A61M2205/3331 , A61M2205/3368 , A61M2205/50 , A61M2205/75 , A61M2209/088
Abstract: Dialysis is enhanced by using nanoclay sorbents to better absorb body wastes in a flow-through system. Nanoclay sorbents, using montmorillonite, bentonite, and other clays, absorb significantly more ammonium, phosphate, and creatinine, and the like, than conventional sorbents. The clays may be used in wearable systems, such as a wearable peritoneal dialysis system, in which the dialysis fluid is circulated through a filter with nanoclay sorbents. Waste products are absorbed by the nanoclays and the dialysis fluid is recycled to the patient's peritoneum. Using the ion-exchange capability of the nanoclays, waste ions in the dialysis fluid are replaced with desirable ions, such as calcium, magnesium, and bicarbonate. The nanoclay sorbents are also useful for refreshing dialysis fluid used in hemodialysis and thus reducing the quantity of dialysis fluid needed for hemodialysis.
Abstract translation: 通过使用纳米粘土吸附剂更好地吸收流通系统中的身体废物来增强透析。 使用蒙脱石，膨润土和其他粘土的Nanoclay吸附剂比常规吸附剂更能吸收更多的铵，磷酸盐和肌酸酐等。 粘土可用于可佩戴的系统中，例如穿戴式腹膜透析系统，其中透析液体通过具有纳米粘土吸附剂的过滤器循环。 废物被纳米粘土吸收，透析液再循环到患者腹膜。 使用纳米粘土的离子交换能力，透析液中的废离子被替换为理想的离子，例如钙，镁和碳酸氢盐。 纳米粘土吸附剂也可用于清除血液透析中使用的透析液，从而减少血液透析所需的透析液量。
-
Patent Agency Ranking
公开(公告)号：US20090275883A1
公开(公告)日：2009-11-05
申请号：US12431479
申请日：2009-04-28
Applicant: Paul Chapman , Brian Connell , Ying-Cheng Lo
Inventor： Paul Chapman , Brian Connell , Ying-Cheng Lo
CPC classification number: G06F19/3406 , A61M1/28 , A61M1/282 , A61M2205/3569 , A61M2205/6054 , A61M2205/6072 , G06F19/00 , G06F19/3481 , G16H40/63
Abstract: A peritoneal dialysis system includes: a dialysis fluid container associated with an identifier; a reader for reading the identifier; a signal transmitter for communicating data based on the identifier; and a patient transfer set for semi-permanent connection to a patient, the patient transfer set including: (i) a signal receiver for receiving the data sent by the signal transmitter, (ii) an output device for communicating with the patient, and (iii) electronics configured to received the data and command the output device to communicate with the patient accordingly.
Abstract translation: 腹膜透析系统包括：与标识符相关联的透析液容器; 用于读取标识符的读取器; 信号发送器，用于基于所述标识符传送数据; 以及用于与患者半永久连接的患者转移组，所述患者转移组包括：（i）用于接收由所述信号发送器发送的数据的信号接收器，（ii）用于与患者通信的输出装置，和 iii）被配置为接收数据并命令输出设备相应地与患者通信的电子设备。
-
公开(公告)号：US20090275881A1
公开(公告)日：2009-11-05
申请号：US12431458
申请日：2009-04-28
Applicant: Ying-Cheng Lo , Alp Akonur , Isaac Martis
Inventor： Ying-Cheng Lo , Alp Akonur , Isaac Martis
CPC classification number: G06F19/3481 , A61M1/28 , A61M1/281 , A61M1/282 , A61M2205/3569 , A61M2205/52 , A61M2205/6018 , A61M2205/6054 , A61M2205/6072 , G06F19/00
Abstract: Peritoneal dialysis therapy outcomes have been calculated for a variety of dwell times of peritoneal dialysis fluids in the peritoneal cavities of dialysis patients using kinetic modeling. The length of dwell time should not be the same for every patient, but should vary according to the patient condition and needs. Some patients have a potential for expressing greater ultrafiltrate into the dialysis fluid, and these patients can benefit from a longer dwell time, whereas other patients with less potential will not benefit from a longer dwell time. An optimal or peak time is observed for each peritoneal dialysis therapy outcome, such as ultrafiltrate volume rate, urea clearance (Kt/V), and creatinine clearance, while minimizing hydrocarbon absorption. These values and input parameters can be used to tailor the peritoneal dialysis dwell time for each patient, estimating the peak dwell time that will yield the best therapy outcome for each patient.
Abstract translation: 已经使用动力学模型计算了透析患者腹膜腔腹膜透析液的各种停留时间的腹膜透析治疗结果。 每个患者的停留时间长度不应相同，但应根据患者情况和需要而变化。 一些患者有可能在透析液中表达更多的超滤液，这些患者可以从更长的停留时间中受益，而潜在的潜力较小的患者不会受益于更长的停留时间。 对于每个腹膜透析治疗结果观察到最佳或高峰时间，例如超滤液体积率，尿素清除率（Kt / V）和肌酐清除率，同时使烃吸收最小化。 这些值和输入参数可用于定制每个患者的腹膜透析停留时间，估计将为每位患者产生最佳治疗结果的峰值停留时间。
-
公开(公告)号：US20070278155A1
公开(公告)日：2007-12-06
申请号：US11530842
申请日：2006-09-11
Applicant: Ying-Cheng Lo , Robert W. Childers , Thomas D. Kelly , Justin Rohde
Inventor： Ying-Cheng Lo , Robert W. Childers , Thomas D. Kelly , Justin Rohde
IPC: A61M37/00
CPC classification number: A61M1/1639 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1635 , A61M1/166 , A61M1/28 , A61M1/284 , A61M1/34 , A61M1/3627 , A61M2205/127 , A61M2205/3331 , A61M2205/3368 , A61M2205/502 , Y10T29/49826
Abstract: A kidney failure therapy system includes: (a) a dilaysate supply; (b) at least one valve actuator; (c) at least one pump actuator; and (d) a disposable unit including first and second flexible sheets sealed together for form: (i) at least one flow path configured to be placed in fluid communication with the dilaysate supply; and operable with the at least one valve actuator; and (ii) at least one pumping portion configured to operate with the at least one pump actuator.
Abstract translation: 肾衰竭治疗系统包括：（a）稀释供应; （b）至少一个阀致动器; （c）至少一个泵致动器; 和（d）包括密封在一起的第一和第二柔性片的一次性单元，用于形成：（i）至少一个流路，被配置为与所述稀释片供应流体连通; 并且可与所述至少一个阀致动器一起操作; 和（ii）配置成与所述至少一个泵致动器一起操作的至少一个泵送部分。
-
49.发明授权Bearing and umbilicus gimbal with bearing retainer in blood processing system 失效轴承和脐带万向架与血液处理系统中的轴承保持架公开(公告)号：US06344020B1
公开(公告)日：2002-02-05
申请号：US09455203
申请日：1999-12-06
Applicant: Douglas Reitz , Ying-Cheng Lo , John Joseph Belle , Richard West , Timothy Patno
Inventor： Douglas Reitz , Ying-Cheng Lo , John Joseph Belle , Richard West , Timothy Patno
IPC: B04B700
CPC classification number: F16C33/44 , B04B5/0442 , B04B2005/045 , B04B2005/0492 , F16C23/084 , F16C33/41
Abstract: A bearing supports a rotating element. The bearing comprises an inner annular body and an outer annular body about the inner annular body. A bearing surface, which is located between the inner annular body and the outer annular body, supports the outer annular body for rotation about the inner annular body. A cage supports the bearing surface during rotation of the outer annular body about the inner annular body. The cage includes a material that imparts increased flexural modulus that resists deformation during rotation.
Abstract translation: 轴承支撑旋转元件。 轴承包括内环形体和围绕内环形体的外环形体。 位于内部环形体和外部环形体之间的支承表面支撑外部环形体以围绕内部环形体旋转。 在外环形体围绕内环形体旋转期间，保持架支撑轴承表面。 笼子包括赋予旋转时抵抗变形的增加的弯曲模量的材料。
-
公开(公告)号：US5948385A
公开(公告)日：1999-09-07
申请号：US940579
申请日：1997-09-30
Applicant: John R. Chapman , Ying-Cheng Lo , Winnie Kubey , Clifford J. Holmes , David Bell
Inventor： John R. Chapman , Ying-Cheng Lo , Winnie Kubey , Clifford J. Holmes , David Bell
CPC classification number: A61L31/16 , A01N59/12 , A61K47/48176 , A61K47/48192 , A61K47/482 , A61L15/46 , A61L17/005 , A61L2300/202 , A61L2300/404 , A61L2300/602
Abstract: An antimicrobial material incorporated with a molecular halogen is provided. The antimicrobial material includes a plastic material and a molecular halogen entrapped within the plastic material. A directional release material is also provided in the present application. The directional release material allows for the control of the rate and site of halogen release. Still further, method of impregnating a plastic material are also provided.
Abstract translation: 提供了掺有分子卤素的抗微生物材料。 抗微生物材料包括塑料材料和被包埋在塑料材料内的分子卤素。 在本申请中还提供定向释放材料。 定向释放材料允许控制卤素释放的速率和位置。 此外，还提供了浸渍塑料材料的方法。
-
-
-
-
-
-
-
-
-
Search Results
83
records
(took 0.035 seconds)
